Evonik has launched a non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene® is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene. Non-GMP samples of PhytoSquene® are available immediately with GMP quality to follow in 2023.
Nouryon joined forces with water treatment company Van Remmen UV Technology on a novel method to address the growing concern of pharmaceutical micropollutants in waste water. The process, which combines the Advanox™ ultraviolet (UV) treatment process from Van Remmen UV Technology and Nouryon’s MicrOx™ hydrogen peroxide, is expected to remove more than 90% of pharmaceutical residues.
IL BIOECONOMISTA 